Many of these miRNAs converge on the NF-κB signaling pathway (Figure 7), a central regulator of inflammation, immune responses, and cellular stress, which is widely implicated in both AD and comorbid conditions such as diabetes and hypertension. Here, NFKB1 is linked to diabetes mellitus.